209 related articles for article (PubMed ID: 18171452)
21. [Effects and mechanisms of psychotherapy in the treatment of attention deficit hyperactivity disorder (ADHD) in children and adults].
Philipsen A; van Elst LT; Lesch KP; Jans T; Warnke A
Psychother Psychosom Med Psychol; 2009; 59(3-4):132-40. PubMed ID: 19350473
[TBL] [Abstract][Full Text] [Related]
22. Parental attitudes and involvement in psychopharmacological treatment for ADHD: a conceptual model.
dosReis S; Myers MA
Int Rev Psychiatry; 2008 Apr; 20(2):135-41. PubMed ID: 18386203
[TBL] [Abstract][Full Text] [Related]
23. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
24. Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children.
Horn WF; Ialongo NS; Pascoe JM; Greenberg G; Packard T; Lopez M; Wagner A; Puttler L
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):233-40. PubMed ID: 2016227
[TBL] [Abstract][Full Text] [Related]
25. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
26. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
[TBL] [Abstract][Full Text] [Related]
27. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
Liu C; Robin AL; Brenner S; Eastman J
Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
[TBL] [Abstract][Full Text] [Related]
28. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?
Sandler AD; Glesne CE; Bodfish JW
J Dev Behav Pediatr; 2010 Jun; 31(5):369-75. PubMed ID: 20495473
[TBL] [Abstract][Full Text] [Related]
29. Management of attention deficit hyperactivity disorder: a parental perspective.
Concannon PE; Tang YP
J Paediatr Child Health; 2005 Dec; 41(12):625-30. PubMed ID: 16398864
[TBL] [Abstract][Full Text] [Related]
30. Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication.
Hansen DL; Hansen EH
Qual Health Res; 2006 Nov; 16(9):1267-85. PubMed ID: 17038757
[TBL] [Abstract][Full Text] [Related]
31. What "Dr. Mom" ordered: a community-based exploratory study of parental self-care responses to children's ADHD symptoms.
Bussing R; E Koro-Ljungberg M; Williamson P; Gary FA; Wilson Garvan C
Soc Sci Med; 2006 Aug; 63(4):871-82. PubMed ID: 16644078
[TBL] [Abstract][Full Text] [Related]
32. The effect of methylphenidate on postural stability under single and dual task conditions in children with attention deficit hyperactivity disorder - a double blind randomized control trial.
Jacobi-Polishook T; Shorer Z; Melzer I
J Neurol Sci; 2009 May; 280(1-2):15-21. PubMed ID: 19217632
[TBL] [Abstract][Full Text] [Related]
33. Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.
Aman MG; Marks RE; Turbott SH; Wilsher CP; Merry SN
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):246-56. PubMed ID: 2016229
[TBL] [Abstract][Full Text] [Related]
34. Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo.
Buitelaar JK; Wilens TE; Zhang S; Ning Y; Feldman PD
J Child Psychol Psychiatry; 2009 Mar; 50(3):335-42. PubMed ID: 19309330
[TBL] [Abstract][Full Text] [Related]
35. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures.
Pelham WE; Swanson JM; Furman MB; Schwindt H
J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519
[TBL] [Abstract][Full Text] [Related]
36. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
So CY; Leung PW; Hung SF
Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
[TBL] [Abstract][Full Text] [Related]
37. Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.
Cheon KA; Cho DY; Koo MS; Song DH; Namkoong K
Biol Psychiatry; 2009 Apr; 65(7):564-70. PubMed ID: 19150055
[TBL] [Abstract][Full Text] [Related]
38. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
[TBL] [Abstract][Full Text] [Related]
39. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD.
Adler LA; Spencer T; McGough JJ; Jiang H; Muniz R
J Atten Disord; 2009 Mar; 12(5):449-59. PubMed ID: 19218542
[TBL] [Abstract][Full Text] [Related]
40. [Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].
Stasik D; Tucha O; Tucha L; Walitza S; Lange KW
Psychiatr Pol; 2009; 43(2):183-92. PubMed ID: 19697788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]